{
  "0": {
    "resourceType": "ResearchStudy",
    "id": "research-study-example-0",
    "identifier": [
      {
        "system": "http://clinicaltrials.gov",
        "value": "NCT00000001"
      }
    ],
    "title": "Study of Drug A in Hypertension",
    "status": "active",
    "phase": {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
          "code": "phase-3",
          "display": "Phase 3"
        }
      ]
    },
    "category": [
      {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "interventional",
            "display": "Interventional"
          }
        ]
      }
    ],
    "focus": [
      {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "372733002",
            "display": "Drug A"
          }
        ]
      }
    ],
    "condition": [
      {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "38341003",
            "display": "Hypertension"
          }
        ]
      }
    ],
    "description": "A randomized, double-blind study to evaluate the efficacy of Drug A in treating hypertension.",
    "period": {
      "start": "2023-01-01",
      "end": "2025-12-31"
    },
    "sponsor": {
      "reference": "Organization/sponsor-example"
    },
    "principalInvestigator": {
      "reference": "Practitioner/pi-example"
    },
    "arm": [
      {
        "name": "Drug A 10mg",
        "type": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/study-arm-type",
              "code": "experimental",
              "display": "Experimental"
            }
          ]
        },
        "description": "Participants receive 10mg of Drug A daily"
      },
      {
        "name": "Placebo",
        "type": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/study-arm-type",
              "code": "placebo-comparator",
              "display": "Placebo Comparator"
            }
          ]
        },
        "description": "Participants receive placebo daily"
      }
    ],
    "objective": [
      {
        "name": "Primary Efficacy",
        "type": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/research-study-objective-type",
              "code": "primary",
              "display": "Primary"
            }
          ]
        }
      }
    ]
  },
  "1": {
    "resourceType": "ResearchStudy",
    "id": "research-study-example-1",
    "identifier": [
      {
        "system": "http://clinicaltrials.gov",
        "value": "NCT00000002"
      }
    ],
    "title": "Observational Study of Diabetes Risk Factors",
    "status": "completed",
    "category": [
      {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "observational",
            "display": "Observational"
          }
        ]
      }
    ],
    "condition": [
      {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "44054006",
            "display": "Diabetes mellitus type 2"
          }
        ]
      }
    ],
    "period": {
      "start": "2020-01-01",
      "end": "2023-12-31"
    },
    "enrollment": [
      {
        "reference": "Group/cohort-example"
      }
    ]
  },
  "2": {
    "resourceType": "ResearchStudy",
    "id": "research-study-example-2",
    "identifier": [
      {
        "system": "http://example.org/studies",
        "value": "STUDY-XYZ-2023"
      }
    ],
    "title": "Vaccine Safety Study",
    "status": "in-review",
    "phase": {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
          "code": "phase-1",
          "display": "Phase 1"
        }
      ]
    },
    "focus": [
      {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "398827000",
            "display": "Vaccine"
          }
        ]
      }
    ],
    "description": "Safety assessment of a novel vaccine candidate",
    "contact": [
      {
        "name": "Study Coordinator",
        "telecom": [
          {
            "system": "email",
            "value": "coordinator@example.org"
          }
        ]
      }
    ]
  },
  "3": {
    "resourceType": "ResearchStudy",
    "id": "research-study-example-3",
    "identifier": [
      {
        "system": "http://example.org/studies",
        "value": "STUDY-ABC-2024"
      }
    ],
    "title": "Multi-center Cancer Treatment Study",
    "status": "closed-to-accrual",
    "phase": {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
          "code": "phase-2",
          "display": "Phase 2"
        }
      ]
    },
    "condition": [
      {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "363346000",
            "display": "Malignant neoplasm"
          }
        ]
      }
    ],
    "period": {
      "start": "2022-06-01"
    },
    "site": [
      {
        "reference": "Location/hospital-1"
      },
      {
        "reference": "Location/hospital-2"
      }
    ],
    "note": [
      {
        "text": "Recruitment completed ahead of schedule"
      }
    ]
  }
}
